Cleveland Clinic researchers are unlocking quantum computing's full potential through the creation of a new computing ...
We conducted a phase 2, randomized, placebo-controlled trial of TAK-994, an oral orexin receptor 2–selective agonist, in patients with narcolepsy type 1. Patients with confirmed narcolepsy type 1 ...
At SNHU, we want to make sure you have the information you need to make decisions about your education and your future—no matter where you choose to go to school. That's why our informational articles ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results